Utility Study in Diffuse Large B-Cell Lymphoma (DLBCL)

UK Utility Study in Diffuse Large B-Cell Lymphoma

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02708732

Enrollment

Registered

2016-03-15

Start date

2016-05-31

Completion date

2016-10-31

Last updated

2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diffuse Large B-Cell Lymphoma

Brief summary

This study is a prospective, cross-sectional survey to be administered to real patients in remission from DLBCL using a 15-minute postal or online survey. The project is designed to describe the impact of DLBCL remission on health utility and quality of life. Data collection will occur over a 4-month period.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adults greater than or equal to (\>/=) 18 years of age * Diagnosis of DLBCL and currently in first remission * Prior drug treatment for DLBCL

Exclusion criteria

* Receiving active treatment for DLBCL * Relapsed following any treatment for DLBCL

Design outcomes

Primary

Measure	Time frame
Health-Related Quality of Life According to European Quality of Life 5-Dimension 5-Level (EQ-5D-5L) Score	Up to 4 months of data collection

Countries

United Kingdom

Outcome results